Breaking News

Today Show Full Stories X To view all stories in expanded form, please subscribe. Get Free Trial Send Info
Recommendations	Humanigen price target raised to $36 from $34 at H.C. Wainwright » 06:07 04/12/21 04/12 06:07 04/12/21 06:07 HGEN Humanigen $17.26 / +0.45 (+2.68%) H.C. Wainwright analyst… H.C. Wainwright analyst Joseph Pantginis raised the firm's price target on Humanigen to $36 from $34 and keeps a Buy rating on the shares. At the end of March, Humanigen announced a topline data readout from its Phase 3 trial evaluating lenzilumab in hospitalized COVID-19 patients, Pantginis tells investors in a research note. A significant takeaway from the announcement is that the study concluded lenzilumab can improve the relative rates of survival, particularly COVID-19 patients that did not require invasive mechanical ventilation by 54%, Pantginis tells investors in a research note. The analyst believes lenzilumab differentiates itself in the space by improving survival outcomes in a diverse COVID-19 patient population. ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Options HGEN Humanigen $17.26 / +0.45 (+2.68%) 04/09/21 Humanigen to announce ifabotuzumab data at AACR annual meeting 03/29/21 Humanigen trading resumes 03/29/21 Humanigen trading halted, volatility trading pause 03/29/21 Humanigen reports Phase 3 results demonstrating lenzilumab improves survival HGEN Humanigen $17.26 / +0.45 (+2.68%) 03/29/21 JPMorgan Humanigen upside reaction 'somewhat overdone,' says JPMorgan 03/29/21 RBC Capital Humanigen lenzilumab update 'an incremental positive' for Avid, says RBC Capital 03/29/21 Roth Capital Humanigen price target raised to $35 from $25 at Roth Capital 02/23/21 JPMorgan Humanigen initiated with a Neutral at JPMorgan HGEN Humanigen $17.26 / +0.45 (+2.68%) 03/10/21 Humanigen reports Q4 EPS (63c), consensus (67c) 11/11/20 Humanigen reports Q3 EPS (71c), consensus (49c) 31 Mar 18 Sep HGEN Humanigen $17.26 / +0.45 (+2.68%) 03/29/21 Fly Intel: Wall Street's top stories for Monday 03/29/21 Fly Intel: Wall Street's top stories at midday 03/29/21 Fly Intel: Pre-market Movers 12/17/20 Fly Intel: Wall Street's top stories for Thursday HGEN Humanigen $17.26 / +0.45 (+2.68%) 04/05/21 Largest borrow rate increases among liquid names 03/29/21 Unusually active option classes on open March 29th 03/25/21 Largest borrow rate increases among liquid names 03/18/21 Unusually active option classes on open March 18th

Friday
Hot Stocks	Humanigen to announce ifabotuzumab data at AACR annual meeting » 07:06 04/09/21 04/09 07:06 04/09/21 07:06 HGEN Humanigen $16.79 / +0.1 (+0.60%) Humanigen (HGEN)… Humanigen (HGEN) announced results from the Phase 1 safety and bioimaging trial of its second Humaneered antibody, ifabotuzumab, in patients with glioblastoma multiforme, or GBM. In the study, ifabotuzumab demonstrated sensitive, specific, and reproducible targeting of the tumor and tumor microenvironment in all patients. The results will be presented as a poster at the AACR annual meeting, held virtually from April 10-15, and remain available until June 21. The Phase 1 study primarily sought to determine the safety and recommended Phase 2 dose of ifabotuzumab in patients with GBM, the most frequent and lethal primary brain neoplasm, with 5-year survival rates of 10%. The study showed that, at both doses, ifabotuzumab demonstrated highly sensitive, specific, and reproducible targeting of the tumor and tumor microenvironment in all patients. There were no dose-limiting toxicities observed and all adverse events were readily manageable. Additional studies are planned to evaluate ifabotuzumab as an antibody-drug conjugate in solid tumor patients. ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Options HGEN Humanigen $16.79 / +0.1 (+0.60%) 03/29/21 Humanigen trading resumes 03/29/21 Humanigen trading halted, volatility trading pause 03/29/21 Humanigen reports Phase 3 results demonstrating lenzilumab improves survival 03/02/21 Humanigen says COVID trial not suspended, error being corrected by NIH HGEN Humanigen $16.79 / +0.1 (+0.60%) 03/29/21 JPMorgan Humanigen upside reaction 'somewhat overdone,' says JPMorgan 03/29/21 RBC Capital Humanigen lenzilumab update 'an incremental positive' for Avid, says RBC Capital 03/29/21 Roth Capital Humanigen price target raised to $35 from $25 at Roth Capital 02/23/21 JPMorgan Humanigen initiated with a Neutral at JPMorgan HGEN Humanigen $16.79 / +0.1 (+0.60%) 03/10/21 Humanigen reports Q4 EPS (63c), consensus (67c) 11/11/20 Humanigen reports Q3 EPS (71c), consensus (49c) 31 Mar 18 Sep HGEN Humanigen $16.79 / +0.1 (+0.60%) 03/29/21 Fly Intel: Wall Street's top stories for Monday 03/29/21 Fly Intel: Wall Street's top stories at midday 03/29/21 Fly Intel: Pre-market Movers 12/17/20 Fly Intel: Wall Street's top stories for Thursday HGEN Humanigen $16.79 / +0.1 (+0.60%) 04/05/21 Largest borrow rate increases among liquid names 03/29/21 Unusually active option classes on open March 29th 03/25/21 Largest borrow rate increases among liquid names 03/18/21 Unusually active option classes on open March 18th

Over a week ago
Options	Largest borrow rate increases among liquid names » 08:45 04/05/21 04/05 08:45 04/05/21 08:45 HGEN Humanigen $19.20 / -0.08 (-0.41%) , ARKK ARK Innovation ETF $120.84 / +0.99 (+0.83%) , CLVR Clever Leaves $10.80 / +0.465 (+4.50%) , LGHL Lion Group $3.65 / -0.76 (-17.23%) , ONCT Oncternal Therapeutics $8.35 / +0.06 (+0.72%) , GOEV Canoo $9.02 / -0.01 (-0.11%) , TM Toyota $154.12 / -1.99 (-1.27%) , TAK Takeda Pharmaceutical $18.64 / +0.375 (+2.05%) , FAII Fortress Value Acquisition Corp. II $10.09 / +0.115 (+1.15%) Latest data shows the… Latest data shows the largest indicative borrow rate increases among liquid option names include: Humanigen (HGEN) 19.74% +13.19, ARK Innovation ETF (ARKK) 34.25% +11.23, Clever Leaves (CLVR) 35.09% +8.34, Lion Group Holding Ltd (LGHL) 38.50% +7.70, Oncternal Therapeutics (ONCT) 82.77% +6.08, Burgundy Technology Acquition Corp (BTAQ) 5.62% +4.40, Canoo (GOEV) 16.19% +3.39, Toyota (TM) 3.79% +3.33, Takeda Pharmaceutical (TAK) 7.82% +3.26, and Fortress Value Acquisition Corp II (FAII) 9.11% +3.14. ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options Technical Analysis TM TAK ONCT LGHL HGEN GOEV FAII CLVR ARKK TM Toyota $154.12 / -1.99 (-1.27%) 04/01/21 Toyota reports March U.S. sales up 79.8% on DSR basis to 253,783 vehicles 03/17/21 EU passenger car registrations down 19.3% in February 02/18/21 Toyota West Virginia announces $210M investment, 100 new jobs 02/17/21 EU passenger car registrations down 24.0% in January TAK Takeda Pharmaceutical $18.64 / +0.375 (+2.05%) 03/31/21 Takeda Pharmaceutical completes sale of OTC, non-core assets to Orifarm 03/30/21 Ovid Therapeutics, Takeda close agreement for commercialization of soticlestat 03/15/21 Takeda granted orphan status for pouchitis treatment vedolizumab 03/15/21 Eledon Pharmaceuticals names Paul Little as CFO, Jeff Bornstein as CMO ONCT Oncternal Therapeutics $8.35 / +0.06 (+0.72%) 01/14/21 Oncternal Therapeutics confirms agreement with Lentigen Technology 01/07/21 Oncternal, Karolinska Institutet in pact for ROR1-targeting cell therapy 12/07/20 Oncternal Therapeutics presents interim phase 1/2 data update for cirmtuzumab 11/11/20 Oncternal Therapeutics to present interim Phase 1 trial data for TK216 LGHL Lion Group $3.65 / -0.76 (-17.23%) 03/08/21 Lion Group to form a second SPAC company, Aquarius I Acquisition Corp. 03/01/21 Lion Group announces sponsorship of SPAC company 02/22/21 Lion Group announces strategic partnership with Grandshores Technology 01/12/21 Lion Group to acquire 100% of Lion FinTech Group HGEN Humanigen $19.20 / -0.08 (-0.41%) 03/29/21 Humanigen trading resumes 03/29/21 Humanigen trading halted, volatility trading pause 03/29/21 Humanigen reports Phase 3 results demonstrating lenzilumab improves survival 03/02/21 Humanigen says COVID trial not suspended, error being corrected by NIH GOEV Canoo $9.02 / -0.01 (-0.11%) 03/29/21 Canoo sees Q1 operating expenses $45M-$50M 03/29/21 Canoo names Renato Giger as interim CFO 03/11/21 Canoo say production version of EV pickup truck opens for preorders in Q2 FAII Fortress Value Acquisition Corp. II $10.09 / +0.115 (+1.15%) 02/22/21 ATI Physical Therapy to become public through $2.5B FVAC II merger agreement CLVR Clever Leaves $10.80 / +0.465 (+4.50%) 04/01/21 Clever Leaves expands presence in Brazil, Peru through Verdemed partnership 03/17/21 Clever Leaves, Ethypharm announce German pharmaceutical cannabis partnership 03/02/21 Clever Leaves receives largest 2021 production quotas from Colombian Government 02/22/21 Clever Leaves appoints Hank Hague as CFO ARKK ARK Innovation ETF $120.84 / +0.99 (+0.83%) 03/18/21 Teladoc among ARK Investment Management's latest trades HGEN ARKK CLVR LGHL ONCT GOEV TM TAK FAII HGEN Humanigen $19.20 / -0.08 (-0.41%) 03/29/21 JPMorgan Humanigen upside reaction 'somewhat overdone,' says JPMorgan 03/29/21 RBC Capital Humanigen lenzilumab update 'an incremental positive' for Avid, says RBC Capital 03/29/21 Roth Capital Humanigen price target raised to $35 from $25 at Roth Capital 02/23/21 JPMorgan Humanigen initiated with a Neutral at JPMorgan ARKK ARK Innovation ETF $120.84 / +0.99 (+0.83%) CLVR Clever Leaves $10.80 / +0.465 (+4.50%) LGHL Lion Group $3.65 / -0.76 (-17.23%) ONCT Oncternal Therapeutics $8.35 / +0.06 (+0.72%) 03/30/21 Fly Intel: Top five analyst initiations 03/30/21 Brookline Oncternal Therapeutics initiated with a Buy at Brookline 02/23/21 Northland Northland starts $7 Oncternal Therapeutics at Outperform with $21 target 02/23/21 Northland Oncternal Therapeutics initiated with an Outperform at Northland GOEV Canoo $9.02 / -0.01 (-0.11%) 03/30/21 Roth Capital Canoo downgraded to Neutral at Roth Capital on 'complete change in direction' 03/30/21 Roth Capital Canoo downgraded to Neutral from Buy at Roth Capital 03/11/21 R.F. Lafferty Canoo initiated with a Buy at R.F. Lafferty TM Toyota $154.12 / -1.99 (-1.27%) 03/30/21 Citi Toyota resumed with a Buy at Citi 09/14/20 Credit Suisse Toyota upgraded to Outperform from Neutral at Credit Suisse 09/08/20 Bernstein Bernstein sees Tesla's current valuation as 'mind-boggling' 07/29/20 Morgan Stanley Tesla price target raised to $1,050 from $740 at Morgan Stanley TAK Takeda Pharmaceutical $18.64 / +0.375 (+2.05%) 04/05/21 Jefferies Takeda Pharmaceutical downgraded to Hold from Buy at Jefferies 03/03/21 RBC Capital Ovid downgraded to Sector Perform at RBC Capital after rally on Takeda deal 01/29/21 Morgan Stanley Morgan Stanley downgrades Jazz to Equal Weight ahead of competitor readout 12/29/20 Needham Needham names Phathom Pharmaceuticals Top Pick for 2021 FAII Fortress Value Acquisition Corp. II $10.09 / +0.115 (+1.15%) TM TAK ONCT HGEN GOEV TM Toyota $154.12 / -1.99 (-1.27%) 02/10/21 Toyota reports nine months EPS Y525.23 vs. Y608.73 last year 11/06/20 Toyota sees FY21 sales revenue Y26T, operating income Y1.3B 11/06/20 Toyota reports 1H EPS Y223.81 vs. Y403.51 last year TAK Takeda Pharmaceutical $18.64 / +0.375 (+2.05%) 04/05/21 Molecular Templates to assume full rights of TAK-169 from Takeda ONCT Oncternal Therapeutics $8.35 / +0.06 (+0.72%) 03/11/21 Oncternal Therapeutics reports Q4 EPS (9c), two estimates (18c) HGEN Humanigen $19.20 / -0.08 (-0.41%) 03/10/21 Humanigen reports Q4 EPS (63c), consensus (67c) 11/11/20 Humanigen reports Q3 EPS (71c), consensus (49c) GOEV Canoo $9.02 / -0.01 (-0.11%) 03/29/21 Canoo reports Q4 EPS (8c), one estimate (14c) 31 Mar 18 Nov 18 Sep 28 Aug TM TAK GOEV TM Toyota $154.12 / -1.99 (-1.27%) 03/31/21 Toyota, Nissan potential production cuts due to Renesas fire, Nikkei reports 03/19/21 Toyota disclosed potential Thai antibribery violations to DOJ, SEC, WSJ reports 03/17/21 Toyota, Honda halting some NA production amid supply shortages, WSJ reports 03/02/21 Toyota does not plan to ask Texas workers to stop wearing masks, Reuters says TAK Takeda Pharmaceutical $18.64 / +0.375 (+2.05%) 10/09/20 Takeda, others testing convalescent plasma treatment in Covid, WSJ reports GOEV Canoo $9.02 / -0.01 (-0.11%) 01/13/21 Apple held talks with EV startup Canoo last year, Verge says TM TAK HGEN GOEV FAII CLVR TM Toyota $154.12 / -1.99 (-1.27%) 04/01/21 Fly Intel: Wall Street's top stories at midday TAK Takeda Pharmaceutical $18.64 / +0.375 (+2.05%) 03/03/21 Fly Intel: Wall Street's top stories for Wednesday 03/03/21 Fly Intel: Wall Street's top stories at midday 03/03/21 Fly Intel: Pre-market Movers HGEN Humanigen $19.20 / -0.08 (-0.41%) 03/29/21 Fly Intel: Wall Street's top stories for Monday 03/29/21 Fly Intel: Wall Street's top stories at midday 03/29/21 Fly Intel: Pre-market Movers 12/17/20 Fly Intel: Wall Street's top stories for Thursday GOEV Canoo $9.02 / -0.01 (-0.11%) 03/30/21 Fly Intel: Wall Street's top stories for Tuesday 03/30/21 Fly Intel: Wall Street's top stories at midday 03/30/21 Canoo slides after first post SPAC-IPO results, business model pivot 03/29/21 Fly Intel: After-Hours Movers FAII Fortress Value Acquisition Corp. II $10.09 / +0.115 (+1.15%) 02/22/21 Fly Intel: Pre-market Movers CLVR Clever Leaves $10.80 / +0.465 (+4.50%) 02/18/21 Rising High: An exclusive talk with multinational cannabis company Clever Leaves 04/08/21 Electric Vehicle Virtual Conference 04/06/21 Takeda Pharmaceutical - TAK TAK ONCT LGHL HGEN GOEV FAII CLVR ARKK TAK Takeda Pharmaceutical $18.64 / +0.375 (+2.05%) 03/19/21 Takeda Pharmaceutical call volume above normal and directionally bullish 03/17/21 Unusually active option classes on open March 17th 01/22/21 Takeda Pharmaceutical call volume above normal and directionally bullish ONCT Oncternal Therapeutics $8.35 / +0.06 (+0.72%) 02/16/21 Largest borrow rate increases among liquid names 12/16/20 Eight new option listings and one option delisting on December 16th LGHL Lion Group $3.65 / -0.76 (-17.23%) 03/17/21 new option listings on March 17th HGEN Humanigen $19.20 / -0.08 (-0.41%) 03/29/21 Unusually active option classes on open March 29th 03/25/21 Largest borrow rate increases among liquid names 03/18/21 Unusually active option classes on open March 18th GOEV Canoo $9.02 / -0.01 (-0.11%) 03/29/21 Canoo options imply 9.9% move in share price post-earnings 03/18/21 Canoo call volume above normal and directionally bullish 03/17/21 Canoo call volume above normal and directionally bullish 03/16/21 Unusually active option classes on open March 16th FAII Fortress Value Acquisition Corp. II $10.09 / +0.115 (+1.15%) 03/23/21 Largest borrow rate increases among liquid names CLVR Clever Leaves $10.80 / +0.465 (+4.50%) 03/29/21 Largest borrow rate increases among liquid names 03/26/21 Largest borrow rate increases among liquid names 03/19/21 Largest borrow rate increases among liquid names 03/05/21 Largest borrow rate increases among liquid names ARKK ARK Innovation ETF $120.84 / +0.99 (+0.83%) 03/18/21 DOOM put Buyer in ARK Innovation ETF 03/09/21 Unusually active option classes on open March 9th 02/26/21 Unusually active option classes on open February 26th 02/25/21 Largest borrow rate increases among liquid names ARKK ARKK ARK Innovation ETF $120.84 / +0.99 (+0.83%) 04/01/21 On The Fly: ETF fund flow highlights 02/26/21 On The Fly: ETF fund flow highlights 01/29/21 On The Fly: ETF fund flow highlights 12/31/20 On The Fly: ETF fund flow highlights
Syndicate	Humanigen 5M share Secondary priced at $18.50 » 20:20 03/30/21 03/30 20:20 03/30/21 20:20 HGEN Humanigen $21.62 / -0.07 (-0.32%) The deal priced below the… The deal priced below the last closing price of $21.67. Jefferies, Credit Suisse and Cantor Fitzgerald are acting as joint book running managers for the offering. ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Options HGEN Humanigen $21.62 / -0.07 (-0.32%) 03/29/21 Humanigen trading resumes 03/29/21 Humanigen trading halted, volatility trading pause 03/29/21 Humanigen reports Phase 3 results demonstrating lenzilumab improves survival 03/02/21 Humanigen says COVID trial not suspended, error being corrected by NIH HGEN Humanigen $21.62 / -0.07 (-0.32%) 03/29/21 JPMorgan Humanigen upside reaction 'somewhat overdone,' says JPMorgan 03/29/21 RBC Capital Humanigen lenzilumab update 'an incremental positive' for Avid, says RBC Capital 03/29/21 Roth Capital Humanigen price target raised to $35 from $25 at Roth Capital 02/23/21 JPMorgan Humanigen initiated with a Neutral at JPMorgan HGEN Humanigen $21.62 / -0.07 (-0.32%) 03/10/21 Humanigen reports Q4 EPS (63c), consensus (67c) 11/11/20 Humanigen reports Q3 EPS (71c), consensus (49c) 31 Mar 18 Sep HGEN Humanigen $21.62 / -0.07 (-0.32%) 03/29/21 Fly Intel: Wall Street's top stories for Monday 03/29/21 Fly Intel: Wall Street's top stories at midday 03/29/21 Fly Intel: Pre-market Movers 12/17/20 Fly Intel: Wall Street's top stories for Thursday HGEN Humanigen $21.62 / -0.07 (-0.32%) 03/29/21 Unusually active option classes on open March 29th 03/25/21 Largest borrow rate increases among liquid names 03/18/21 Unusually active option classes on open March 18th
On The Fly	Fly Intel: Wall Street's top stories for Monday » 16:31 03/29/21 03/29 16:31 03/29/21 16:31 NWSA News Corp. $25.03 / -0.7 (-2.72%) , BA Boeing $250.81 / +5.96 (+2.43%) , LUV Southwest $60.96 / -0.32 (-0.52%) , CS Credit Suisse $11.38 / -1.485 (-11.54%) , NMR Nomura $5.68 / -0.94 (-14.20%) , PFE Pfizer $36.62 / +0.37 (+1.02%) , MRNA Moderna $123.35 / -9.8 (-7.36%) , BNTX BioNTech $95.74 / +0.21 (+0.22%) , HGEN Humanigen $21.69 / +7.68 (+54.82%) , HMHC Houghton Mifflin $7.11 / +1.115 (+18.61%) , CG Carlyle Group $36.37 / -0.37 (-1.01%) , CLDX Celldex $20.50 / -3.51 (-14.62%) , GSX GSX Techedu $31.84 / -7.17 (-18.38%) The major averages were… Open Full Text ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options PFE NWSA NMR MRNA LUV HMHC HGEN GSX CS CLDX CG BNTX BA PFE Pfizer $36.62 / +0.37 (+1.02%) 03/29/21 CDC estimates real-world mRNA vaccine effectiveness of 90% at full immunization 03/26/21 BioNTech: EMA approves manufacturing of Covid vaccine at Marburg facility 03/26/21 EMA approves new storage option for Pfizer-BioNTech vaccine 03/25/21 Pfizer says FDA adcom voted 1 for, 19 against on question of REMS for tanezumab NWSA News Corp. $25.03 / -0.7 (-2.72%) 03/29/21 News Corp. to acquire HMH Books & Media for $349M in cash 03/29/21 Houghton Mifflin to divest HMH Books & Media to News Corp. unit for $349M 03/25/21 News Corp to acquire Investor's Business Daily for $275M 03/15/21 Facebook, News Corp reach multi-year agreement in Australia NMR Nomura $5.68 / -0.94 (-14.20%) 03/29/21 Nomura falls -13.2% 03/29/21 Nomura falls -13.2% 03/29/21 Nomura falls -13.5% 03/29/21 Nomura falls 14% to $5.70 after warning of 'significant loss' with U.S. client MRNA Moderna $123.35 / -9.8 (-7.36%) 03/29/21 Moderna ships 100M doses of COVID-19 vaccine to U.S. Government 03/22/21 Moderna announces supply agreement with Philippines for 7M vaccine doses 03/16/21 Moderna doses first patients in KidCOVE vaccine Phase 2/3 study LUV Southwest $60.96 / -0.32 (-0.52%) 01/31/21 Fly Intel: Top five weekend stock stories 01/28/21 Southwest says it has cut 2020-2021 planned CapEx by $5B HMHC Houghton Mifflin $7.11 / +1.115 (+18.61%) 03/28/21 Fly Intel: Top five weekend stock stories 02/25/21 Houghton Mifflin sees 2021 billings $1.10B-$1.15B 11/05/20 Houghton Mifflin sees FY20 billings $1.05B-$1.1B HGEN Humanigen $21.69 / +7.68 (+54.82%) 03/29/21 Humanigen trading resumes 03/29/21 Humanigen trading halted, volatility trading pause 03/29/21 Humanigen reports Phase 3 results demonstrating lenzilumab improves survival 03/02/21 Humanigen says COVID trial not suspended, error being corrected by NIH GSX GSX Techedu $31.84 / -7.17 (-18.38%) 03/29/21 GSX Techedu falls -12.7% 03/26/21 GSX Techedu trading resumes 03/26/21 GSX Techedu down 43% to $38.12 in volatile afternoon trading 03/26/21 GSX Techedu trading halted, volatility trading pause CS Credit Suisse $11.38 / -1.485 (-11.54%) 03/29/21 Credit Suisse falls -13.2% 03/29/21 Credit Suisse falls -13.3% 03/29/21 Credit Suisse falls 11% to $11.40 after warning of hedge fund loss in Q1 03/29/21 Credit Suisse says hedge fund default could bring 'highly significant' Q1 loss CLDX Celldex $20.50 / -3.51 (-14.62%) 03/29/21 Celldex reports 80% complete response rate from Phase 1b study of CDX-0159 02/22/21 Celldex to expand development of CDX-0159 into prurigo nodularis 01/04/21 Celldex appoints Freddy Jimenez as SVP, general counsel 12/09/20 Celldex doses first patient in Phase 1b study of CDX-0159 CG Carlyle Group $36.37 / -0.37 (-1.01%) 03/29/21 Carlyle Aviation to acquire Fly Leasing for $17.05 per share, or about $2.36B EV 03/02/21 Oglethorpe enters purchase, sale agreement to acquire Effingham County Power 02/28/21 Fly Intel: Top five weekend stock stories 02/10/21 Carlyle Group CEO sells 140.7K shares of commons tock BNTX BioNTech $95.74 / +0.21 (+0.22%) 03/11/21 Evidence confirms high effectiveness of Pfizer, BioNTech COVID-19 vaccine BA Boeing $250.81 / +5.96 (+2.43%) 03/29/21 Southwest orders 100 Boeing 737 MAX jets, plus 155 options 03/29/21 Southwest adds 100 firm orders for Boeing 737 MAX 7 03/23/21 Kaman Composites awarded contract by Boeing over MH-47 program 03/18/21 Boeing, NASA complete Artemis hot fire test of space launch system core stage NWSA BA LUV CS NMR PFE MRNA BNTX HGEN HMHC CG CLDX GSX NWSA News Corp. $25.03 / -0.7 (-2.72%) 03/18/21 Fly Intel: Top five analyst upgrades 03/18/21 Guggenheim Guggenheim upgrades News Corp. to Buy, sees 'significant value' to be unlocked 03/18/21 Guggenheim News Corp. upgraded to Buy from Neutral at Guggenheim 02/12/21 Fly Intel: Top five analyst upgrades BA Boeing $250.81 / +5.96 (+2.43%) 03/29/21 Goldman Sachs Boeing resuming 787 deliveries removes overhang, says Goldman Sachs 03/19/21 Susquehanna Boeing price target raised to $300 from $250 at Susquehanna 03/15/21 Morgan Stanley Aerospace sector upgraded to Attractive from Cautious at Morgan Stanley 03/15/21 Morgan Stanley Boeing price target raised to $274 from $250 at Morgan Stanley LUV Southwest $60.96 / -0.32 (-0.52%) 03/23/21 Fly Intel: Top five analyst upgrades 03/23/21 Argus Southwest upgraded to Buy from Hold at Argus 03/23/21 Argus Southwest upgraded to Buy from Hold at Argus 03/16/21 Goldman Sachs Southwest price target raised to $69 from $47 at Goldman Sachs CS Credit Suisse $11.38 / -1.485 (-11.54%) 03/30/21 Citi Credit Suisse buyback likely suspended on Archegos losses, says Citi 03/29/21 Deutsche Bank Credit Suisse price target lowered to CHF 15 from CHF 16 at Deutsche Bank 03/29/21 Fly Intel: Top five analyst downgrades 03/29/21 BofA Credit Suisse downgraded to Neutral from Buy at BofA NMR Nomura $5.68 / -0.94 (-14.20%) 03/29/21 JPMorgan Nomura downgraded to Underweight from Neutral at JPMorgan 03/09/21 Goldman Sachs Nomura upgraded to Buy from Neutral at Goldman Sachs 03/01/21 Citi Nomura upgraded to Neutral from Sell at Citi PFE Pfizer $36.62 / +0.37 (+1.02%) 03/17/21 Mizuho AbbVie's FDA request show Xeljanz concerns may bleed to Rinvoq, says Mizuho 02/23/21 B. Riley B. Riley remains 'aggressive' buyer of Novavax after updated FDA guidance 02/10/21 KeyBanc Maravai Lifesciences price target raised to $39 from $33 at KeyBanc 02/04/21 DZ Bank Pfizer upgraded to Buy from Hold at DZ Bank MRNA Moderna $123.35 / -9.8 (-7.36%) 03/15/21 Piper Sandler Piper Sandler bullish on Moderna as first subject vaccinated in '1283 study 03/01/21 Chardan Moderna price target raised to $182 from $107 at Chardan 02/26/21 Barclays Moderna price target raised to $178 from $169 at Barclays 02/26/21 Brookline Moderna price target raised to $205 from $180 at Brookline BNTX BioNTech $95.74 / +0.21 (+0.22%) 02/01/21 SVB Leerink Moderna price target raised to $80 from $69 at SVB Leerink 01/29/21 Piper Sandler Moderna, Pfizer keep Covid vaccine competitive advantage, says Piper Sandler 01/14/21 Morgan Stanley 80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley HGEN Humanigen $21.69 / +7.68 (+54.82%) 03/29/21 JPMorgan Humanigen upside reaction 'somewhat overdone,' says JPMorgan 03/29/21 RBC Capital Humanigen lenzilumab update 'an incremental positive' for Avid, says RBC Capital 03/29/21 Roth Capital Humanigen price target raised to $35 from $25 at Roth Capital 02/23/21 JPMorgan Humanigen initiated with a Neutral at JPMorgan HMHC Houghton Mifflin $7.11 / +1.115 (+18.61%) 03/03/21 BMO Capital Houghton Mifflin price target raised to $6 from $3 at BMO Capital 12/15/20 Citi Houghton Mifflin price target raised to $3.45 from $3 at Citi 11/24/20 Citi Houghton Mifflin price target raised to $3 from $2.50 at Citi 10/05/20 Citi Houghton Mifflin upgraded to Neutral from Sell at Citi CG Carlyle Group $36.37 / -0.37 (-1.01%) 02/24/21 Deutsche Bank Carlyle Group price target raised to $39 from $37 at Deutsche Bank 02/24/21 Barclays Carlyle Group price target raised to $39 from $36 at Barclays 02/19/21 Fly Intel: Top five analyst upgrades 02/19/21 Credit Suisse Carlyle Group upgraded to Outperform from Neutral at Credit Suisse CLDX Celldex $20.50 / -3.51 (-14.62%) 03/29/21 H.C. Wainwright Celldex selloff on CDX-0159 data 'undeserved,' says H.C. Wainwright 02/23/21 H.C. Wainwright Celldex price target raised to $36 from $25 at H.C. Wainwright 02/23/21 Cantor Fitzgerald Celldex price target raised to $35 from $22 at Cantor Fitzgerald 10/19/20 H.C. Wainwright Celldex price target raised to $25 from $16 at H.C. Wainwright GSX GSX Techedu $31.84 / -7.17 (-18.38%) 03/29/21 Fly Intel: Top five analyst upgrades 03/29/21 Citi Citi double upgrades GSX Techedu to Buy after Friday's 'overdone' selloff 03/29/21 Citi GSX Techedu upgraded to Buy from Sell at Citi 03/08/21 Barclays GSX Techedu price target raised to $73 from $63 at Barclays PFE NWSA MRNA LUV HMHC HGEN GSX CS CLDX CG BA PFE Pfizer $36.62 / +0.37 (+1.02%) 02/02/21 Pfizer raises FY21 adjusted EPS view to $3.10-$3.20, consensus $3.19 02/02/21 Pfizer raises FY21 adjusted EPS view to $3.10-$3.20, consensus $3.19 02/02/21 Pfizer reports Q4 adjusted EPS 42c, consensus 48c 02/01/21 Notable companies reporting before tomorrow's open NWSA News Corp. $25.03 / -0.7 (-2.72%) 02/04/21 News Corp. reports Q2 adjutsed EPS 34c, consensus 10c 11/05/20 News Corp. reports Q1 adjusted EPS 8c, consensus 0c MRNA Moderna $123.35 / -9.8 (-7.36%) 02/25/21 Moderna reports Q4 EPS (69c), consensus (35c) 02/24/21 Notable companies reporting before tomorrow's open 10/29/20 Moderna reports Q3 EPS (59c), consensus (43c) LUV Southwest $60.96 / -0.32 (-0.52%) 01/28/21 Southwest reports Q4 ex-items EPS ($1.29), consensus ($1.68) 01/27/21 Notable companies reporting before tomorrow's open 11/12/20 Southwest reports October operating revenue down about 65% year-over-year HMHC Houghton Mifflin $7.11 / +1.115 (+18.61%) 02/25/21 Houghton Mifflin reports Q4 EPS (66c), consensus (51c) 11/05/20 Houghton Mifflin reports Q3 EPS (10c), consensus 53c HGEN Humanigen $21.69 / +7.68 (+54.82%) 03/10/21 Humanigen reports Q4 EPS (63c), consensus (67c) 11/11/20 Humanigen reports Q3 EPS (71c), consensus (49c) GSX GSX Techedu $31.84 / -7.17 (-18.38%) 03/05/21 GSX Techedu sees Q1 revenue up 40%-43% versus last year 03/05/21 GSX Techedu reports Q4 EPS (39c), consensus (38c) 11/20/20 GSX Techedu reports Q3 EPS (57c), consensus (31c) CS Credit Suisse $11.38 / -1.485 (-11.54%) 02/18/21 Credit Suisse reports Q4 adjusted pretax income CHF861M vs. CHF955M last year CLDX Celldex $20.50 / -3.51 (-14.62%) 03/29/21 Celldex reports Q4 EPS (55c), consensus (37c) 11/05/20 Celldex reports Q3 EPS (36c), consensus (36c) CG Carlyle Group $36.37 / -0.37 (-1.01%) 02/23/21 Carlyle Group targets more than $1.6B in distributable earnings by 2024 02/04/21 Carlyle Group reports Q4 distributable income/share 64c, consensus 45c 02/03/21 Notable companies reporting before tomorrow's open BA Boeing $250.81 / +5.96 (+2.43%) 01/27/21 Boeing reports Q4 core EPS ($15.25), consensus ($1.80) 01/26/21 Notable companies reporting before tomorrow's open 10/28/20 Boeing reports Q3 core EPS ($1.39), consensus ($2.32) 31 Mar 12 Mar 18 Sep 23 Jul 16 Jun 19 May 29 Apr PFE NWSA MRNA LUV HMHC GSX CS CG BNTX BA PFE Pfizer $36.62 / +0.37 (+1.02%) 03/26/21 White House weighs lifting IP protections for COVID-19 vaccines, CNBC says 03/25/21 Biden to up 100-day COVID-19 vaccination goal to 200M shots, CNBC says 03/23/21 WTO's Okonjo-Iweala 'disappointed' in EU vaccine export scheme, Reuters says 03/23/21 Pfizer to expand mRNA vaccine business beyond Covid, WSJ reports NWSA News Corp. $25.03 / -0.7 (-2.72%) 11/24/20 Bertelsmann in lead to buy Simon & Schuster from ViacomCBS, FT reports 11/17/20 News Corp. to bid for ViacomCBS publisher Simon & Schuster, FT reports MRNA Moderna $123.35 / -9.8 (-7.36%) 03/03/21 Some Catholic bishops advise against certain Covid-19 vaccines, WSJ reports LUV Southwest $60.96 / -0.32 (-0.52%) 03/18/21 Biden administration looks to ease travel restrictions in mid-May, CNBC says 03/10/21 Boeing near deal with Southwest for 737 MAX order, Reuters reports 02/11/21 Southwest in talks for at least 300 new 150-seat planes, Air Current says 02/10/21 Southwest CEO urges Biden not to mandate domestic air COVID testing, Reuters says HMHC Houghton Mifflin $7.11 / +1.115 (+18.61%) 03/28/21 News Corp. nears deal to buy Houghton Mifflin consumer-publishing arm, WSJ says GSX GSX Techedu $31.84 / -7.17 (-18.38%) 12/18/20 Seven whistleblowers have described 'fraud' at GSX Techedu, Aurelius Value says 10/12/20 WSJ article on GSX 'somewhat misses the point,' Muddy Waters says 10/12/20 GSX proves to be one of the year's worst short bets, WSJ says CS Credit Suisse $11.38 / -1.485 (-11.54%) 03/22/21 Credit Suisse hit with additional EU antitrust charges over forex, Reuters says 03/21/21 Credit Suisse CEO signals possible spinoff of asset management, Bloomberg says 03/16/21 Credit Suisse may take charges on Greensill loan, WSJ reports 03/02/21 French bankers want new EU law to move euro clearing to Frankfurt, Reuters says CG Carlyle Group $36.37 / -0.37 (-1.01%) 03/17/21 Fly Leasing receives six bids for aircraft leasing portfolio, AFJ reports 02/28/21 Twilio nears up to $750M investment in Syniverse, WSJ reports 01/07/21 Carlyle working with banks on rival bid for Signature Aviation, Sky News says 10/25/20 Carlyle nearing $2.4B deal for Siemen's Flender business, Bloomberg says BNTX BioNTech $95.74 / +0.21 (+0.22%) 03/26/21 EMA poised to approve BioNTech, AstraZeneca vaccine sites, Bloomberg says 03/24/21 BioNTech vaccines temporarily suspended in Hong Kong, Macau, Bloomberg says BA Boeing $250.81 / +5.96 (+2.43%) 03/29/21 Boeing urges Delaware court to dismiss investors' 737 MAX lawsuit, Reuters says 03/26/21 Boeing confirms 787 Dreamliner deliveries have resumed, Bloomberg says 03/25/21 Boeing may resume 787 Dreamliner deliveries this Friday, Bloomberg says 03/25/21 Boeing may resume 787 Dreamliner deliveries this Friday, Bloomberg says PFE NWSA MRNA LUV HGEN GSX CS CG BNTX BA PFE Pfizer $36.62 / +0.37 (+1.02%) 03/23/21 Fly Intel: Wall Street's top stories for Tuesday 03/23/21 Fly Intel: Wall Street's top stories at midday NWSA News Corp. $25.03 / -0.7 (-2.72%) 03/29/21 Fly Intel: Wall Street's top stories for Monday 03/17/21 #SocialStocks: Facebook dabbles in news, publishing 11/25/20 Fly Intel: Wall Street's top stories for Wednesday 11/25/20 Fly Intel: Wall Street's top stories at midday MRNA Moderna $123.35 / -9.8 (-7.36%) 03/16/21 Fly Intel: Wall Street's top stories for Tuesday 03/16/21 Fly Intel: Wall Street's top stories at midday LUV Southwest $60.96 / -0.32 (-0.52%) 03/23/21 Netflix, Southwest upgrades among today's top calls on Wall Street 02/22/21 Airbnb, Snap upgrades among today's top calls on Wall Street HGEN Humanigen $21.69 / +7.68 (+54.82%) 12/17/20 Fly Intel: Wall Street's top stories for Thursday GSX GSX Techedu $31.84 / -7.17 (-18.38%) 03/08/21 Fly Intel: Wall Street's top stories for Monday 03/08/21 Fly Intel: Wall Street's top stories at midday CS Credit Suisse $11.38 / -1.485 (-11.54%) 03/29/21 Analysts upgrade ViacomCBS, GSX Techedu as selloff in shares continues 03/29/21 Fly Intel: Pre-market Movers CG Carlyle Group $36.37 / -0.37 (-1.01%) 11/30/20 Fly Insider: Merrimack, Catalent among weeks notable insider trades BNTX BioNTech $95.74 / +0.21 (+0.22%) 02/19/21 Fly Intel: Wall Street's top stories for Friday 02/19/21 Fly Intel: Wall Street's top stories at midday BA Boeing $250.81 / +5.96 (+2.43%) 03/29/21 Fly Intel: Wall Street's top stories at midday 03/09/21 Fly Intel: Wall Street's top stories for Tuesday 03/09/21 Fly Intel: Wall Street's top stories at midday 04/08/21 Biotech;Biopharma 05/24/21 Global Healthcare Virtual Conference 2021 03/30/21 BioNTech - BNTX 04/27/21 Nomura - NMR 05/04/21 Pfizer - PFE 12/29/21 PDUFA Date for Lorbrena (Lorlatinib) April 2021 04/20/21 Boeing Co. 04/22/21 Pfizer Inc 04/28/21 Moderna, Inc. 05/14/21 Houghton Mifflin Harcourt Company PFE NWSA MRNA LUV HGEN GSX CS CG BNTX BA PFE Pfizer $36.62 / +0.37 (+1.02%) 03/15/21 Pfizer call volume above normal and directionally bullish 03/04/21 Pfizer call volume above normal and directionally bullish 01/29/21 Unusually active option classes on open January 29th 01/25/21 Pfizer call volume above normal and directionally bullish NWSA News Corp. $25.03 / -0.7 (-2.72%) 02/12/21 Early notable gainers among liquid option names on February 12th 02/05/21 Early notable gainers among liquid option names on February 5th 11/06/20 Early notable gainers among liquid option names on November 6th MRNA Moderna $123.35 / -9.8 (-7.36%) 03/17/21 Moderna call volume above normal and directionally bullish 03/01/21 Moderna call volume above normal and directionally bullish 02/01/21 Moderna call volume above normal and directionally bullish 01/25/21 Moderna call volume above normal and directionally bullish LUV Southwest $60.96 / -0.32 (-0.52%) 03/08/21 Early notable gainers among liquid option names on March 8th 02/22/21 Southwest put volume heavy and directionally bearish 02/08/21 Southwest call volume above normal and directionally bullish 01/11/21 Unusually active option classes on open January 11th HGEN Humanigen $21.69 / +7.68 (+54.82%) 03/25/21 Largest borrow rate increases among liquid names 03/18/21 Unusually active option classes on open March 18th 09/30/20 Thirteen new option listings and two option delistings on September 30th GSX GSX Techedu $31.84 / -7.17 (-18.38%) 03/10/21 GSX Techedu put volume heavy and directionally bearish 03/08/21 GSX Techedu put volume heavy and directionally bearish 03/04/21 GSX Techedu put volume heavy and directionally bearish 03/03/21 GSX Techedu put volume heavy and directionally bearish CS Credit Suisse $11.38 / -1.485 (-11.54%) 03/12/21 Unusually active option classes on open March 12th 03/11/21 Unusually active option classes on open March 11th 12/08/20 Largest borrow rate increases among liquid names 11/20/20 Credit Suisse call volume above normal and directionally bullish CG Carlyle Group $36.37 / -0.37 (-1.01%) 12/02/20 Unusual call flow in option market yesterday BNTX BioNTech $95.74 / +0.21 (+0.22%) 02/17/21 Largest borrow rate increases among liquid names 01/26/21 BioNTech SE put volume heavy and directionally bearish 01/19/21 Largest borrow rate increases among liquid names 11/23/20 Largest borrow rate increases among liquid names BA Boeing $250.81 / +5.96 (+2.43%) 03/29/21 Early notable gainers among liquid option names on March 29th 03/29/21 Unusually active option classes on open March 29th 03/17/21 Call buyers board Boeing as shares gain altitude following 2day slide 03/17/21 Early notable gainers among liquid option names on March 17th

Syndicate	Humanigen files to sell 5M shares of common stock » 16:13 03/29/21 03/29 16:13 03/29/21 16:13 HGEN Humanigen $21.66 / +7.65 (+54.60%) Jefferies, Credit Suisse… Jefferies, Credit Suisse and Cantor are acting as joint book-running managers for the offering. Bryan, Garnier & Co. is acting as European lead manager for the offering, Oppenheimer & Co. is acting as lead manager for the offering and H.C. Wainwright & Co., National Securities Corporation and Roth Capital Partners are acting as co-managers for the offering. ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Options HGEN Humanigen $21.66 / +7.65 (+54.60%) 03/29/21 Humanigen trading resumes 03/29/21 Humanigen trading halted, volatility trading pause 03/29/21 Humanigen reports Phase 3 results demonstrating lenzilumab improves survival 03/02/21 Humanigen says COVID trial not suspended, error being corrected by NIH HGEN Humanigen $21.66 / +7.65 (+54.60%) 03/29/21 JPMorgan Humanigen upside reaction 'somewhat overdone,' says JPMorgan 03/29/21 RBC Capital Humanigen lenzilumab update 'an incremental positive' for Avid, says RBC Capital 03/29/21 Roth Capital Humanigen price target raised to $35 from $25 at Roth Capital 02/23/21 JPMorgan Humanigen initiated with a Neutral at JPMorgan HGEN Humanigen $21.66 / +7.65 (+54.60%) 03/10/21 Humanigen reports Q4 EPS (63c), consensus (67c) 11/11/20 Humanigen reports Q3 EPS (71c), consensus (49c) 18 Sep HGEN Humanigen $21.66 / +7.65 (+54.60%) 03/29/21 Fly Intel: Wall Street's top stories at midday 03/29/21 Fly Intel: Pre-market Movers 12/17/20 Fly Intel: Wall Street's top stories for Thursday 12/17/20 Fly Intel: Wall Street's top stories at midday HGEN Humanigen $21.66 / +7.65 (+54.60%) 03/29/21 Unusually active option classes on open March 29th 03/25/21 Largest borrow rate increases among liquid names 03/18/21 Unusually active option classes on open March 18th 09/30/20 Thirteen new option listings and two option delistings on September 30th
Recommendations	Humanigen upside reaction 'somewhat overdone,' says JPMorgan » 13:23 03/29/21 03/29 13:23 03/29/21 13:23 HGEN Humanigen $23.72 / +9.71 (+69.31%) After Humanigen announced… After Humanigen announced topline results from the phase 3 trial of lenzilumab in hospitalized COVID-19 patients, JPMorgan analyst Eric Joseph said the results were in-line with his base case scenario and that "the data are limited in their differentiation from other biologic immuno-suppressive regimes available for off-label use in the indication." Though he sees the path toward an emergency use authorization for lenzilumab being "fundamentally de-risked" by the data, he sees "a moderated commercial outlook for the product" and views today's upside reaction in the shares "as somewhat overdone," Joseph tells investors. He keeps a Neutral rating on the stock and continues to view $21 per share as a fair valuation for mid-term, Joseph added. In afternoon trading, Humanigen shares are up $9.16, or 65%, to $23.15. ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Options HGEN Humanigen $23.72 / +9.71 (+69.31%) 03/29/21 Humanigen trading resumes 03/29/21 Humanigen trading halted, volatility trading pause 03/29/21 Humanigen reports Phase 3 results demonstrating lenzilumab improves survival 03/02/21 Humanigen says COVID trial not suspended, error being corrected by NIH HGEN Humanigen $23.72 / +9.71 (+69.31%) 03/29/21 RBC Capital Humanigen lenzilumab update 'an incremental positive' for Avid, says RBC Capital 03/29/21 Roth Capital Humanigen price target raised to $35 from $25 at Roth Capital 02/23/21 JPMorgan Humanigen initiated with a Neutral at JPMorgan 01/20/21 Jefferies Jefferies reads Humanigen COVID-19 trial change as 'sign of confidence' HGEN Humanigen $23.72 / +9.71 (+69.31%) 03/10/21 Humanigen reports Q4 EPS (63c), consensus (67c) 11/11/20 Humanigen reports Q3 EPS (71c), consensus (49c) 18 Sep HGEN Humanigen $23.72 / +9.71 (+69.31%) 03/29/21 Fly Intel: Wall Street's top stories at midday 03/29/21 Fly Intel: Pre-market Movers 12/17/20 Fly Intel: Wall Street's top stories for Thursday 12/17/20 Fly Intel: Wall Street's top stories at midday HGEN Humanigen $23.72 / +9.71 (+69.31%) 03/29/21 Unusually active option classes on open March 29th 03/25/21 Largest borrow rate increases among liquid names 03/18/21 Unusually active option classes on open March 18th 09/30/20 Thirteen new option listings and two option delistings on September 30th
On The Fly	Fly Intel: Wall Street's top stories at midday » 12:08 03/29/21 03/29 12:08 03/29/21 12:08 BA Boeing $251.20 / +6.35 (+2.59%) , LUV Southwest $60.44 / -0.84 (-1.37%) , CS Credit Suisse $11.40 / -1.47 (-11.43%) , NMR Nomura $5.74 / -0.885 (-13.37%) , PFE Pfizer $36.59 / +0.34 (+0.94%) , MRNA Moderna $124.10 / -9.05 (-6.80%) , BNTX BioNTech $94.61 / -0.92 (-0.96%) , HGEN Humanigen $26.70 / +12.69 (+90.58%) , FLY Fly Leasing $16.86 / +3.615 (+27.30%) , CG Carlyle Group $36.49 / -0.25 (-0.68%) , CLDX Celldex $15.55 / -8.46 (-35.24%) , ORPH Orphazyme $8.79 / -3.6 (-29.06%) The major averages are… Open Full Text ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options PFE ORPH NMR MRNA LUV HGEN FLY CS CLDX CG BNTX BA PFE Pfizer $36.59 / +0.34 (+0.94%) 03/29/21 CDC estimates real-world mRNA vaccine effectiveness of 90% at full immunization 03/26/21 BioNTech: EMA approves manufacturing of Covid vaccine at Marburg facility 03/26/21 EMA approves new storage option for Pfizer-BioNTech vaccine 03/25/21 Pfizer says FDA adcom voted 1 for, 19 against on question of REMS for tanezumab ORPH Orphazyme $8.79 / -3.6 (-29.06%) 03/29/21 Orphazyme announces arimoclomol trial does not meet primary endpoint 12/31/20 CytRx says Orphazyme's arimoclomol PDUFA target date extended to June 17, 2021 12/07/20 CytRx announces Orphazyme U.S. expansion ahead of potential arimoclomol approval 11/11/20 CytRx says Orphazyme submited MAA to EMA for arimoclomol for NPC treatment NMR Nomura $5.74 / -0.885 (-13.37%) 03/29/21 Nomura falls -13.2% 03/29/21 Nomura falls -13.2% 03/29/21 Nomura falls -13.5% 03/29/21 Nomura falls 14% to $5.70 after warning of 'significant loss' with U.S. client MRNA Moderna $124.10 / -9.05 (-6.80%) 03/29/21 Moderna ships 100M doses of COVID-19 vaccine to U.S. Government 03/22/21 Moderna announces supply agreement with Philippines for 7M vaccine doses 03/16/21 Moderna doses first patients in KidCOVE vaccine Phase 2/3 study LUV Southwest $60.44 / -0.84 (-1.37%) 01/31/21 Fly Intel: Top five weekend stock stories 01/28/21 Southwest says it has cut 2020-2021 planned CapEx by $5B HGEN Humanigen $26.70 / +12.69 (+90.58%) 03/29/21 Humanigen trading resumes 03/29/21 Humanigen trading halted, volatility trading pause 03/29/21 Humanigen reports Phase 3 results demonstrating lenzilumab improves survival 03/02/21 Humanigen says COVID trial not suspended, error being corrected by NIH FLY Fly Leasing $16.86 / +3.615 (+27.30%) 03/29/21 Fly Leasing rises 27.2% 03/29/21 Fly Leasing rises 25.7% 03/29/21 Fly Leasing rises 26.0% 03/29/21 Carlyle Aviation to acquire Fly Leasing for $17.05 per share, or about $2.36B EV CS Credit Suisse $11.40 / -1.47 (-11.43%) 03/29/21 Credit Suisse falls -13.2% 03/29/21 Credit Suisse falls -13.3% 03/29/21 Credit Suisse falls 11% to $11.40 after warning of hedge fund loss in Q1 03/29/21 Credit Suisse says hedge fund default could bring 'highly significant' Q1 loss CLDX Celldex $15.55 / -8.46 (-35.24%) 03/29/21 Celldex reports 80% complete response rate from Phase 1b study of CDX-0159 02/22/21 Celldex to expand development of CDX-0159 into prurigo nodularis 01/04/21 Celldex appoints Freddy Jimenez as SVP, general counsel 12/09/20 Celldex doses first patient in Phase 1b study of CDX-0159 CG Carlyle Group $36.49 / -0.25 (-0.68%) 03/02/21 Oglethorpe enters purchase, sale agreement to acquire Effingham County Power 02/28/21 Fly Intel: Top five weekend stock stories 02/10/21 Carlyle Group CEO sells 140.7K shares of commons tock BNTX BioNTech $94.61 / -0.92 (-0.96%) 03/11/21 Evidence confirms high effectiveness of Pfizer, BioNTech COVID-19 vaccine BA Boeing $251.20 / +6.35 (+2.59%) 03/29/21 Southwest orders 100 Boeing 737 MAX jets, plus 155 options 03/29/21 Southwest adds 100 firm orders for Boeing 737 MAX 7 03/23/21 Kaman Composites awarded contract by Boeing over MH-47 program 03/18/21 Boeing, NASA complete Artemis hot fire test of space launch system core stage BA LUV CS NMR PFE MRNA BNTX HGEN FLY CG CLDX ORPH BA Boeing $251.20 / +6.35 (+2.59%) 03/29/21 Goldman Sachs Boeing resuming 787 deliveries removes overhang, says Goldman Sachs 03/19/21 Susquehanna Boeing price target raised to $300 from $250 at Susquehanna 03/15/21 Morgan Stanley Aerospace sector upgraded to Attractive from Cautious at Morgan Stanley 03/15/21 Morgan Stanley Boeing price target raised to $274 from $250 at Morgan Stanley LUV Southwest $60.44 / -0.84 (-1.37%) 03/23/21 Fly Intel: Top five analyst upgrades 03/23/21 Argus Southwest upgraded to Buy from Hold at Argus 03/23/21 Argus Southwest upgraded to Buy from Hold at Argus 03/16/21 Goldman Sachs Southwest price target raised to $69 from $47 at Goldman Sachs CS Credit Suisse $11.40 / -1.47 (-11.43%) 03/29/21 Fly Intel: Top five analyst downgrades 03/29/21 BofA Credit Suisse downgraded to Neutral from Buy at BofA 03/17/21 Kepler Cheuvreux Credit Suisse downgraded to Hold from Buy at Kepler Cheuvreux 03/11/21 Goldman Sachs Credit Suisse downgraded to Neutral from Buy at Goldman Sachs NMR Nomura $5.74 / -0.885 (-13.37%) 03/29/21 JPMorgan Nomura downgraded to Underweight from Neutral at JPMorgan 03/09/21 Goldman Sachs Nomura upgraded to Buy from Neutral at Goldman Sachs 03/01/21 Citi Nomura upgraded to Neutral from Sell at Citi PFE Pfizer $36.59 / +0.34 (+0.94%) 03/17/21 Mizuho AbbVie's FDA request show Xeljanz concerns may bleed to Rinvoq, says Mizuho 02/23/21 B. Riley B. Riley remains 'aggressive' buyer of Novavax after updated FDA guidance 02/10/21 KeyBanc Maravai Lifesciences price target raised to $39 from $33 at KeyBanc 02/04/21 DZ Bank Pfizer upgraded to Buy from Hold at DZ Bank MRNA Moderna $124.10 / -9.05 (-6.80%) 03/15/21 Piper Sandler Piper Sandler bullish on Moderna as first subject vaccinated in '1283 study 03/01/21 Chardan Moderna price target raised to $182 from $107 at Chardan 02/26/21 Barclays Moderna price target raised to $178 from $169 at Barclays 02/26/21 Brookline Moderna price target raised to $205 from $180 at Brookline BNTX BioNTech $94.61 / -0.92 (-0.96%) 02/01/21 SVB Leerink Moderna price target raised to $80 from $69 at SVB Leerink 01/29/21 Piper Sandler Moderna, Pfizer keep Covid vaccine competitive advantage, says Piper Sandler 01/14/21 Morgan Stanley 80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley HGEN Humanigen $26.70 / +12.69 (+90.58%) 03/29/21 RBC Capital Humanigen lenzilumab update 'an incremental positive' for Avid, says RBC Capital 03/29/21 Roth Capital Humanigen price target raised to $35 from $25 at Roth Capital 02/23/21 JPMorgan Humanigen initiated with a Neutral at JPMorgan 01/20/21 Jefferies Jefferies reads Humanigen COVID-19 trial change as 'sign of confidence' FLY Fly Leasing $16.86 / +3.615 (+27.30%) 03/19/21 Deutsche Bank Fly Leasing price target raised to $13 from $10 at Deutsche Bank 02/26/21 Deutsche Bank Fly Leasing downgraded to Hold with $10 target at Deutsche Bank 02/26/21 Deutsche Bank Fly Leasing downgraded to Hold from Buy at Deutsche Bank 01/26/21 Cowen Fly Leasing price target raised to $13 from $9 at Cowen CG Carlyle Group $36.49 / -0.25 (-0.68%) 02/24/21 Deutsche Bank Carlyle Group price target raised to $39 from $37 at Deutsche Bank 02/24/21 Barclays Carlyle Group price target raised to $39 from $36 at Barclays 02/19/21 Fly Intel: Top five analyst upgrades 02/19/21 Credit Suisse Carlyle Group upgraded to Outperform from Neutral at Credit Suisse CLDX Celldex $15.55 / -8.46 (-35.24%) 02/23/21 H.C. Wainwright Celldex price target raised to $36 from $25 at H.C. Wainwright 02/23/21 Cantor Fitzgerald Celldex price target raised to $35 from $22 at Cantor Fitzgerald 10/19/20 H.C. Wainwright Celldex price target raised to $25 from $16 at H.C. Wainwright 07/01/20 Cantor Fitzgerald Celldex price target raised to $18 from $12 at Cantor Fitzgerald ORPH Orphazyme $8.79 / -3.6 (-29.06%) 10/26/20 Guggenheim Orphazyme initiated with a Buy at Guggenheim 10/26/20 BofA Orphazyme initiated with a Buy at BofA 10/26/20 BofA Orphazyme initiated with a Buy at BofA PFE MRNA LUV HGEN FLY CS CLDX CG BA PFE Pfizer $36.59 / +0.34 (+0.94%) 02/02/21 Pfizer raises FY21 adjusted EPS view to $3.10-$3.20, consensus $3.19 02/02/21 Pfizer raises FY21 adjusted EPS view to $3.10-$3.20, consensus $3.19 02/02/21 Pfizer reports Q4 adjusted EPS 42c, consensus 48c 02/01/21 Notable companies reporting before tomorrow's open MRNA Moderna $124.10 / -9.05 (-6.80%) 02/25/21 Moderna reports Q4 EPS (69c), consensus (35c) 02/24/21 Notable companies reporting before tomorrow's open 10/29/20 Moderna reports Q3 EPS (59c), consensus (43c) LUV Southwest $60.44 / -0.84 (-1.37%) 01/28/21 Southwest reports Q4 ex-items EPS ($1.29), consensus ($1.68) 01/27/21 Notable companies reporting before tomorrow's open 11/12/20 Southwest reports October operating revenue down about 65% year-over-year HGEN Humanigen $26.70 / +12.69 (+90.58%) 03/10/21 Humanigen reports Q4 EPS (63c), consensus (67c) 11/11/20 Humanigen reports Q3 EPS (71c), consensus (49c) FLY Fly Leasing $16.86 / +3.615 (+27.30%) 02/25/21 Fly Leasing reports Q4 adjusted EPS ($3.78), consensus (15c) 11/12/20 Fly Leasing reports Q3 adjusted EPS (30c), consensus 36c CS Credit Suisse $11.40 / -1.47 (-11.43%) 02/18/21 Credit Suisse reports Q4 adjusted pretax income CHF861M vs. CHF955M last year CLDX Celldex $15.55 / -8.46 (-35.24%) 11/05/20 Celldex reports Q3 EPS (36c), consensus (36c) CG Carlyle Group $36.49 / -0.25 (-0.68%) 02/23/21 Carlyle Group targets more than $1.6B in distributable earnings by 2024 02/04/21 Carlyle Group reports Q4 distributable income/share 64c, consensus 45c 02/03/21 Notable companies reporting before tomorrow's open BA Boeing $251.20 / +6.35 (+2.59%) 01/27/21 Boeing reports Q4 core EPS ($15.25), consensus ($1.80) 01/26/21 Notable companies reporting before tomorrow's open 10/28/20 Boeing reports Q3 core EPS ($1.39), consensus ($2.32) 12 Mar 29 Sep 18 Sep 23 Jul 16 Jun 19 May 29 Apr PFE MRNA LUV FLY CS CG BNTX BA PFE Pfizer $36.59 / +0.34 (+0.94%) 03/26/21 White House weighs lifting IP protections for COVID-19 vaccines, CNBC says 03/25/21 Biden to up 100-day COVID-19 vaccination goal to 200M shots, CNBC says 03/23/21 WTO's Okonjo-Iweala 'disappointed' in EU vaccine export scheme, Reuters says 03/23/21 Pfizer to expand mRNA vaccine business beyond Covid, WSJ reports MRNA Moderna $124.10 / -9.05 (-6.80%) 03/03/21 Some Catholic bishops advise against certain Covid-19 vaccines, WSJ reports LUV Southwest $60.44 / -0.84 (-1.37%) 03/18/21 Biden administration looks to ease travel restrictions in mid-May, CNBC says 03/10/21 Boeing near deal with Southwest for 737 MAX order, Reuters reports 02/11/21 Southwest in talks for at least 300 new 150-seat planes, Air Current says 02/10/21 Southwest CEO urges Biden not to mandate domestic air COVID testing, Reuters says FLY Fly Leasing $16.86 / +3.615 (+27.30%) 03/17/21 Fly Leasing receives six bids for aircraft leasing portfolio, AFJ reports 12/23/20 Fly Leasing rallies after Airfinance Journal says considering sale CS Credit Suisse $11.40 / -1.47 (-11.43%) 03/22/21 Credit Suisse hit with additional EU antitrust charges over forex, Reuters says 03/21/21 Credit Suisse CEO signals possible spinoff of asset management, Bloomberg says 03/16/21 Credit Suisse may take charges on Greensill loan, WSJ reports 03/02/21 French bankers want new EU law to move euro clearing to Frankfurt, Reuters says CG Carlyle Group $36.49 / -0.25 (-0.68%) 02/28/21 Twilio nears up to $750M investment in Syniverse, WSJ reports 01/07/21 Carlyle working with banks on rival bid for Signature Aviation, Sky News says 10/25/20 Carlyle nearing $2.4B deal for Siemen's Flender business, Bloomberg says BNTX BioNTech $94.61 / -0.92 (-0.96%) 03/26/21 EMA poised to approve BioNTech, AstraZeneca vaccine sites, Bloomberg says 03/24/21 BioNTech vaccines temporarily suspended in Hong Kong, Macau, Bloomberg says BA Boeing $251.20 / +6.35 (+2.59%) 03/26/21 Boeing confirms 787 Dreamliner deliveries have resumed, Bloomberg says 03/25/21 Boeing may resume 787 Dreamliner deliveries this Friday, Bloomberg says 03/25/21 Boeing may resume 787 Dreamliner deliveries this Friday, Bloomberg says 03/18/21 FAA strips Boeing's authority to preform pre-delivery safety checks, WSJ reports PFE ORPH MRNA LUV HGEN CS CG BNTX BA PFE Pfizer $36.59 / +0.34 (+0.94%) 03/23/21 Fly Intel: Wall Street's top stories for Tuesday 03/23/21 Fly Intel: Wall Street's top stories at midday 02/19/21 Fly Intel: Wall Street's top stories for Friday 02/19/21 Fly Intel: Wall Street's top stories at midday ORPH Orphazyme $8.79 / -3.6 (-29.06%) 10/04/20 Opening Day: Palantir, Asana go public via direct listings MRNA Moderna $124.10 / -9.05 (-6.80%) 03/16/21 Fly Intel: Wall Street's top stories for Tuesday 03/16/21 Fly Intel: Wall Street's top stories at midday 02/25/21 Fly Intel: Pre-market Movers 02/24/21 Fly Intel: After-Hours Movers LUV Southwest $60.44 / -0.84 (-1.37%) 03/23/21 Netflix, Southwest upgrades among today's top calls on Wall Street 02/22/21 Airbnb, Snap upgrades among today's top calls on Wall Street 01/28/21 Fly Intel: Pre-market Movers 12/11/20 Airline changes, another Tesla downgrade among today's top calls on Wall Street HGEN Humanigen $26.70 / +12.69 (+90.58%) 12/17/20 Fly Intel: Wall Street's top stories for Thursday 12/17/20 Fly Intel: Wall Street's top stories at midday 11/06/20 Fly Intel: Wall Street's top stories for Friday CS Credit Suisse $11.40 / -1.47 (-11.43%) 03/29/21 Fly Intel: Pre-market Movers CG Carlyle Group $36.49 / -0.25 (-0.68%) 11/30/20 Fly Insider: Merrimack, Catalent among weeks notable insider trades BNTX BioNTech $94.61 / -0.92 (-0.96%) 02/18/21 Fly Intel: Wall Street's top stories for Thursday 02/18/21 Fly Intel: Wall Street's top stories at midday BA Boeing $251.20 / +6.35 (+2.59%) 03/09/21 Fly Intel: Wall Street's top stories for Tuesday 03/09/21 Fly Intel: Wall Street's top stories at midday 03/05/21 Boeing upgrade, Nikola downgrade among today's top calls on Wall Street 02/22/21 Fly Intel: Wall Street's top stories for Monday 05/24/21 Global Healthcare Virtual Conference 2021 03/30/21 BioNTech - BNTX 04/27/21 Nomura - NMR 05/04/21 Pfizer - PFE 06/17/21 PDUFA Date for Arimoclomol 12/29/21 PDUFA Date for Lorbrena (Lorlatinib) April 2021 04/20/21 Boeing Co. 04/22/21 Pfizer Inc 04/28/21 Moderna, Inc. PFE MRNA LUV HGEN CS CG BNTX BA PFE Pfizer $36.59 / +0.34 (+0.94%) 03/15/21 Pfizer call volume above normal and directionally bullish 03/04/21 Pfizer call volume above normal and directionally bullish 01/29/21 Unusually active option classes on open January 29th 01/25/21 Pfizer call volume above normal and directionally bullish MRNA Moderna $124.10 / -9.05 (-6.80%) 03/17/21 Moderna call volume above normal and directionally bullish 03/01/21 Moderna call volume above normal and directionally bullish 02/01/21 Moderna call volume above normal and directionally bullish 01/25/21 Moderna call volume above normal and directionally bullish LUV Southwest $60.44 / -0.84 (-1.37%) 03/08/21 Early notable gainers among liquid option names on March 8th 02/22/21 Southwest put volume heavy and directionally bearish 02/08/21 Southwest call volume above normal and directionally bullish 01/11/21 Unusually active option classes on open January 11th HGEN Humanigen $26.70 / +12.69 (+90.58%) 03/25/21 Largest borrow rate increases among liquid names 03/18/21 Unusually active option classes on open March 18th 09/30/20 Thirteen new option listings and two option delistings on September 30th CS Credit Suisse $11.40 / -1.47 (-11.43%) 03/12/21 Unusually active option classes on open March 12th 03/11/21 Unusually active option classes on open March 11th 12/08/20 Largest borrow rate increases among liquid names 11/20/20 Credit Suisse call volume above normal and directionally bullish CG Carlyle Group $36.49 / -0.25 (-0.68%) 12/02/20 Unusual call flow in option market yesterday BNTX BioNTech $94.61 / -0.92 (-0.96%) 02/17/21 Largest borrow rate increases among liquid names 01/26/21 BioNTech SE put volume heavy and directionally bearish 01/19/21 Largest borrow rate increases among liquid names 11/23/20 Largest borrow rate increases among liquid names BA Boeing $251.20 / +6.35 (+2.59%) 03/29/21 Early notable gainers among liquid option names on March 29th 03/29/21 Unusually active option classes on open March 29th 03/17/21 Call buyers board Boeing as shares gain altitude following 2day slide 03/17/21 Early notable gainers among liquid option names on March 17th
Recommendations	Humanigen lenzilumab update 'an incremental positive' for Avid, says RBC Capital » 10:57 03/29/21 03/29 10:57 03/29/21 10:57 CDMO Avid Bioservices $16.97 / +0.13 (+0.77%) , HGEN Humanigen $26.85 / +12.84 (+91.65%) RBC Capital analyst Sean… RBC Capital analyst Sean Dodge notes that Humanigen (HGEN) reported "encouraging" topline results from its Phase 3 lenzilumab clinical trial, which is evaluating efficacy/safety of the drug for patients hospitalized with COVID-19. Back on February 3rd, Avid (CDMO) announced it had entered into a cGMP manufacturing agreement with Humanigen to help expand production capacity for lenzilumab, Dodge adds. The analyst believes the data update increases the chances of an eventual FDA approval, and given Avid currently only has one commercial client, the likely addition of another commercial project enhances his confidence in the longer-term revenue growth outlook. He has an Outperform rating and a $21 price target on Avid's shares. ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Options HGEN CDMO HGEN Humanigen $26.85 / +12.84 (+91.65%) 03/29/21 Humanigen trading resumes 03/29/21 Humanigen trading halted, volatility trading pause 03/29/21 Humanigen reports Phase 3 results demonstrating lenzilumab improves survival 03/02/21 Humanigen says COVID trial not suspended, error being corrected by NIH CDMO Avid Bioservices $16.97 / +0.13 (+0.77%) 02/22/21 Avid Bioservices begins Phase 2 of Myford manufacturing capacity expansion plan 02/03/21 Avid, Humanigen enter into cGMP manufacturing agreement for lenzilumab 02/03/21 Avid Bioservices, Humanigen enter lenzilumab manufacturing services agreement CDMO HGEN CDMO Avid Bioservices $16.97 / +0.13 (+0.77%) 03/16/21 RBC Capital RBC starts Avid Bioservices at Outperform with $21 price target 03/16/21 RBC Capital Avid Bioservices initiated with an Outperform at RBC Capital 02/01/21 KeyBanc Avid Bioservices price target raised to $22 from $12 at KeyBanc 11/09/20 KeyBanc Avid Bioservices initiated with an Overweight at KeyBanc HGEN Humanigen $26.85 / +12.84 (+91.65%) 03/29/21 Roth Capital Humanigen price target raised to $35 from $25 at Roth Capital 02/23/21 JPMorgan Humanigen initiated with a Neutral at JPMorgan 01/20/21 Jefferies Jefferies reads Humanigen COVID-19 trial change as 'sign of confidence' 12/23/20 National Securities Humanigen initiated with a Buy at National Securities HGEN CDMO HGEN Humanigen $26.85 / +12.84 (+91.65%) 03/10/21 Humanigen reports Q4 EPS (63c), consensus (67c) 11/11/20 Humanigen reports Q3 EPS (71c), consensus (49c) CDMO Avid Bioservices $16.97 / +0.13 (+0.77%) 03/08/21 Avid Bioservices raises FY21 revenue view to $88M-$91M from $84M-$88M 03/08/21 Avid Bioservices reports Q3 EPS 1c, consensus (3c) 12/02/20 Avid Bioservices raises FY21 revenue view to 84M-$88M from $76M-$81M 12/02/20 Avid Bioservices reports Q2 EPS 1c, consensus (6c) 10 Dec 18 Sep HGEN CDMO HGEN Humanigen $26.85 / +12.84 (+91.65%) 03/29/21 Fly Intel: Pre-market Movers 12/17/20 Fly Intel: Wall Street's top stories for Thursday 12/17/20 Fly Intel: Wall Street's top stories at midday 11/06/20 Fly Intel: Wall Street's top stories for Friday CDMO Avid Bioservices $16.97 / +0.13 (+0.77%) 03/08/21 Fly Intel: After-Hours Movers 12/09/20 Fly Intel: After-Hours Movers HGEN HGEN Humanigen $26.85 / +12.84 (+91.65%) 03/29/21 Unusually active option classes on open March 29th 03/25/21 Largest borrow rate increases among liquid names 03/18/21 Unusually active option classes on open March 18th 09/30/20 Thirteen new option listings and two option delistings on September 30th
Hot Stocks	Humanigen trading resumes 09:55 03/29/21 03/29 09:55 03/29/21 09:55 HGEN Humanigen $20.30 / +6.29 (+44.90%) ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Options HGEN Humanigen $20.30 / +6.29 (+44.90%) 03/29/21 Humanigen trading halted, volatility trading pause 03/29/21 Humanigen reports Phase 3 results demonstrating lenzilumab improves survival 03/02/21 Humanigen says COVID trial not suspended, error being corrected by NIH 03/02/21 Humanigen awarded two patents from USPTO HGEN Humanigen $20.30 / +6.29 (+44.90%) 03/29/21 Roth Capital Humanigen price target raised to $35 from $25 at Roth Capital 02/23/21 JPMorgan Humanigen initiated with a Neutral at JPMorgan 01/20/21 Jefferies Jefferies reads Humanigen COVID-19 trial change as 'sign of confidence' 12/23/20 National Securities Humanigen initiated with a Buy at National Securities HGEN Humanigen $20.30 / +6.29 (+44.90%) 03/10/21 Humanigen reports Q4 EPS (63c), consensus (67c) 11/11/20 Humanigen reports Q3 EPS (71c), consensus (49c) 18 Sep HGEN Humanigen $20.30 / +6.29 (+44.90%) 03/29/21 Fly Intel: Pre-market Movers 12/17/20 Fly Intel: Wall Street's top stories for Thursday 12/17/20 Fly Intel: Wall Street's top stories at midday 11/06/20 Fly Intel: Wall Street's top stories for Friday HGEN Humanigen $20.30 / +6.29 (+44.90%) 03/29/21 Unusually active option classes on open March 29th 03/25/21 Largest borrow rate increases among liquid names 03/18/21 Unusually active option classes on open March 18th 09/30/20 Thirteen new option listings and two option delistings on September 30th

On The Fly

News and insights, exclusive to thefly.com

09:54	Fly Intel: Top five analyst initiations»
09:54	Fly Intel: Top five analyst downgrades»
09:54	Fly Intel: Top five analyst upgrades»
06:11	GameStop downgraded to Sell from Hold at Ascendiant»
05:33	Canaccord upgrades Tesla with over $1,000 target on 'Apple-esque' ecosystem»

View all On The Fly Stories »

Upcoming
Events (10)

ATXI	PDUFA Date for
GNRS	Greenrose Acquisition - GNRS
	Spring 2021 Transmission, Distribution, Meeting & Mutual Assistance Virtual Conference
ONCY	KOL Webinar on AWARE-1 Data
GRCL ...	20th Annual Virtual Healthcare Virtual Conference
	AACR Virtual Annual Meeting 2021
ADBE ...	Nvidia GTC-21 Virtual Conference
BWEN	Broadwind
TCRR	TCR2 Therapeutics
	Leisure Products

View all of today’s events »

Today’s
Syndicate (0)

No syndicate deals.

View this week’s syndicate »

Get Full Fly Access

Breaking market intelligence sent straight to you: Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.

Up-to-date information on important industry events: Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.

News focused on the companies in your portfolio: Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.

14 Day Free Trial